Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

The use of corticosteroids does not influence CD4+ lymphocyte recovery in HIV-infected patients with advanced immunodeficiency.

van Welzen BJ, de Vries TI, Arends JE, Mudrikova T, Hoepelman AIM.

AIDS Care. 2019 May 27:1-4. doi: 10.1080/09540121.2019.1623376. [Epub ahead of print]

PMID:
31132873
2.

Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017.

Vos LM, Teirlinck AC, Lozano JE, Vega T, Donker GA, Hoepelman AI, Bont LJ, Oosterheert JJ, Meijer A.

Euro Surveill. 2019 May;24(20). doi: 10.2807/1560-7917.ES.2019.24.20.1800469.

3.

Pitfalls of molecular diagnostic testing for Coxiella burnetii DNA on throat swabs.

Buijs SB, Hermans MHA, Agni N, de Vries MC, Hoepelman AIM, Oosterheert JJ, Wever PC.

J Microbiol Methods. 2019 Jul;162:16-20. doi: 10.1016/j.mimet.2019.05.006. Epub 2019 May 14.

PMID:
31100316
4.

Switching tenofovir disoproxil fumarate to tenofovir alafenamide results in a significant decline in parathyroid hormone levels: uncovering the mechanism of tenofovir disoproxil fumarate-related bone loss?

Van Welzen BJ, Thielen MAJ, Mudrikova T, Arends JE, Hoepelman AIM.

AIDS. 2019 Apr 22. doi: 10.1097/QAD.0000000000002238. [Epub ahead of print]

PMID:
31021851
5.

More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients.

Vos LM, Weehuizen JM, Hoepelman AIM, Kaasjager KHAH, Riezebos-Brilman A, Oosterheert JJ.

J Clin Virol. 2019 Jul;116:11-17. doi: 10.1016/j.jcv.2019.04.003. Epub 2019 Apr 7.

PMID:
30999234
6.

New filovirus disease classification and nomenclature.

Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Pawęska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z.

Nat Rev Microbiol. 2019 May;17(5):261-263. doi: 10.1038/s41579-019-0187-4. No abstract available.

PMID:
30926957
7.

Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: A retrospective cohort study.

Weehuizen JM, Wensing AMJ, Mudrikova T, Wit FWNM, Hoepelman AIM.

Int J Antimicrob Agents. 2019 Mar 1. pii: S0924-8579(19)30048-2. doi: 10.1016/j.ijantimicag.2019.02.018. [Epub ahead of print]

PMID:
30831236
8.

High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands.

Vos LM, Oosterheert JJ, Kuil SD, Viveen M, Bont LJ, Hoepelman AIM, Coenjaerts FEJ.

J Clin Virol. 2019 Mar;112:20-26. doi: 10.1016/j.jcv.2019.01.007. Epub 2019 Jan 23.

PMID:
30708281
9.

Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review of diagnostic accuracy and clinical impact studies.

Vos LM, Bruning AHL, Reitsma JB, Schuurman R, Riezebos-Brilman A, Hoepelman AIM, Oosterheert JJ.

Clin Infect Dis. 2019 Jan 28. doi: 10.1093/cid/ciz056. [Epub ahead of print]

PMID:
30689772
10.

Coxiella burnetii in non-Hodgkin lymphoma tissue samples: Innocent until proven otherwise?

van Roeden SE, Hermans MHA, Nooijen PTGA, Herbers A, Bleeker-Rovers CP, Hoepelman AIM, Oosterheert JJ, Wever PC.

Immunobiology. 2019 Mar;224(2):254-261. doi: 10.1016/j.imbio.2018.11.012. Epub 2018 Dec 5.

PMID:
30638649
11.

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?

van Welzen BJ, Mudrikova T, El Idrissi A, Hoepelman AIM, Arends JE.

Infect Dis Ther. 2019 Mar;8(1):33-50. doi: 10.1007/s40121-018-0229-7. Epub 2019 Jan 3. Review.

12.

Overcoming Obstacles in Lipid-lowering Therapy in Patients with HIV - A Systematic Review of Current Evidence.

Dekkers CC, Westerink J, Hoepelman AIM, Arends JE.

AIDS Rev. 2018;20(4):205-219. doi: 10.24875/AIDSRev.18000016.

PMID:
30548018
13.

Chronic Q fever-related complications and mortality: data from a nationwide cohort.

van Roeden SE, Wever PC, Kampschreur LM, Gruteke P, van der Hoek W, Hoepelman AIM, Bleeker-Rovers CP, Oosterheert JJ.

Clin Microbiol Infect. 2018 Dec 10. pii: S1198-743X(18)30766-3. doi: 10.1016/j.cmi.2018.11.023. [Epub ahead of print]

PMID:
30543852
14.

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).

Ten Doesschate T, van Mens SP, van Nieuwkoop C, Geerlings SE, Hoepelman AIM, Bonten MJM.

BMC Infect Dis. 2018 Dec 5;18(1):626. doi: 10.1186/s12879-018-3562-2.

15.

Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.

Lieveld FI, Smit C, Richter C, van Erpecum KJ, Spanier BWM, Gisolf EH, Vrolijk JM, Siersema PD, Hoepelman AIM, Reiss P, Arends JE.

Liver Int. 2019 Mar;39(3):470-483. doi: 10.1111/liv.14000. Epub 2018 Dec 2.

PMID:
30411848
16.

Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms.

Bosman KJ, Wensing AM, Pijning AE, van Snippenberg WJ, van Ham PM, de Jong DM, Hoepelman AI, Nijhuis M.

J Int AIDS Soc. 2018 Sep;21(9):e25185. doi: 10.1002/jia2.25185.

17.

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands.

Kracht PAM, Arends JE, van Erpecum KJ, Urbanus A, Willemse JA, Hoepelman AIM, Croes EA.

Hepatol Med Policy. 2018 Sep 29;3:12. doi: 10.1186/s41124-018-0040-9. eCollection 2018. Review.

18.

Objective and Subjective Improvement of Cognition After Discontinuing Efavirenz in Asymptomatic Patients: A Randomized Controlled Trial.

Hakkers CS, Arends JE, van den Berk GE, Ensing MHM, Hooijenga I, Vink M, van Zandvoort MJE, Hoepelman AIM.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):e14-e22. doi: 10.1097/QAI.0000000000001876.

PMID:
30272630
19.

REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.

Kracht PAM, Arends JE, van Erpecum KJ, Thijsen SFT, Vlaminckx BJM, Weersink AJL, Wensing AMJ, Deege MPH, Dimmendaal M, Stadhouders PHGM, Friederich PW, Verhagen MAMT, Boland GJ, Hoepelman AIM.

Liver Int. 2019 Mar;39(3):455-462. doi: 10.1111/liv.13959. Epub 2018 Oct 16.

PMID:
30204289
20.

Syndromic sample-to-result PCR testing for respiratory infections in adult patients.

Vos LM, Riezebos-Brilman A, Schuurman R, Hoepelman AIM, Oosterheert JJ.

Neth J Med. 2018 Aug;76(6):286-293.

21.

The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study.

Kracht PAM, Lieveld FI, Amelung LM, Verstraete CJR, Mauser-Bunschoten EP, de Bruijne J, Siersema PD, Hoepelman AIM, Arends JE, van Erpecum KJ.

Infect Dis Ther. 2018 Sep;7(3):373-385. doi: 10.1007/s40121-018-0208-z. Epub 2018 Aug 3.

22.

The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients.

Krikke M, Tesselaar K, van den Berk GEL, Otto SA, Freriks LH, van Lelyveld SFL, Visseren FJL, Hoepelman AIM, Arends JE.

HIV Clin Trials. 2018 Apr;19(2):75-83. doi: 10.1080/15284336.2018.1455366.

PMID:
29770748
23.

Primary and secondary arterial fistulas during chronic Q fever.

Karhof S, van Roeden SE, Oosterheert JJ, Bleeker-Rovers CP, Renders NHM, de Borst GJ, Kampschreur LM, Hoepelman AIM, Koning OHJ, Wever PC.

J Vasc Surg. 2018 Dec;68(6):1906-1913.e1. doi: 10.1016/j.jvs.2018.01.044.

PMID:
29685511
24.

Exposure to Coxiella burnetii and risk of non-Hodgkin lymphoma: a retrospective population-based analysis in the Netherlands.

van Roeden SE, van Houwelingen F, Donkers CMJ, Hogewoning SJ, de Lange MMA, van der Hoek W, Kampschreur LM, Bonten MJM, Hoepelman AIM, Bleeker-Rovers CP, Wever PC, Oosterheert JJ.

Lancet Haematol. 2018 May;5(5):e211-e219. doi: 10.1016/S2352-3026(18)30038-3. Epub 2018 Apr 9.

PMID:
29650493
25.

Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8+ T-Cell Subsets.

Veel E, Westera L, van Gent R, Bont L, Otto S, Ruijsink B, Rabouw HH, Mudrikova T, Wensing A, Hoepelman AIM, Borghans JAM, Tesselaar K.

Front Immunol. 2018 Mar 21;9:572. doi: 10.3389/fimmu.2018.00572. eCollection 2018.

26.

The effect of measuring serum doxycycline concentrations on clinical outcomes during treatment of chronic Q fever.

van Roeden SE, Bleeker-Rovers CP, Kampschreur LM, de Regt MJA, Vermeulen Windsant A, Hoepelman AIM, Wever PC, Oosterheert JJ.

J Antimicrob Chemother. 2018 Apr 1;73(4):1068-1076. doi: 10.1093/jac/dkx487.

PMID:
29325142
27.

Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance.

Fun A, Leitner T, Vandekerckhove L, Däumer M, Thielen A, Buchholz B, Hoepelman AIM, Gisolf EH, Schipper PJ, Wensing AMJ, Nijhuis M.

Retrovirology. 2018 Jan 5;15(1):1. doi: 10.1186/s12977-017-0384-z.

28.

The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.

Hakkers CS, Beunders AJM, Ensing MHM, Barth RE, Boelema S, Devillé WLJ, Tempelman HA, Coutinho RA, Hoepelman AIM, Arends JE, van Zandvoort MJE.

Int J Infect Dis. 2018 Feb;67:36-40. doi: 10.1016/j.ijid.2017.11.024. Epub 2017 Nov 26.

29.

Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens.

van Roeden SE, Bleeker-Rovers CP, de Regt MJA, Kampschreur LM, Hoepelman AIM, Wever PC, Oosterheert JJ.

Clin Infect Dis. 2018 Feb 10;66(5):719-726. doi: 10.1093/cid/cix886.

PMID:
29040457
30.

Rapid Tests for Common Respiratory Viruses.

Vos LM, Riezebos-Brilman A, Hoepelman AIM, Oosterheert JJ.

Clin Infect Dis. 2017 Nov 13;65(11):1958-1959. doi: 10.1093/cid/cix700. No abstract available.

PMID:
29020183
31.

Case report: Coxiella burnetii vascular infection and lymphoma in the Netherlands.

van Roeden SE, Melenotte C, Hermans MHA, Sinnige HAM, Nooijen PTGA, Audoly G, Hoepelman AIM, Oosterheert JJ, Raoult D, Wever PC.

Infection. 2018 Feb;46(1):131-134. doi: 10.1007/s15010-017-1061-9. Epub 2017 Aug 24.

32.

HIV and Cognitive Impairment in Clinical Practice: The Evaluation of a Stepwise Screening Protocol in Relation to Clinical Outcomes and Management.

Hakkers CS, Kraaijenhof JM, van Oers-Hazelzet EB, Visser-Meily AJMA, Hoepelman AIM, Arends JE, Barth RE.

AIDS Patient Care STDS. 2017 Sep;31(9):363-369. doi: 10.1089/apc.2017.0022. Epub 2017 Aug 7.

PMID:
28783374
33.

Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.

Nuralitha S, Siregar JE, Syafruddin D, Hoepelman AIM, Marzuki S.

Malar J. 2017 May 23;16(1):216. doi: 10.1186/s12936-017-1860-6.

34.

Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.

Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.

Neth J Med. 2017 May;75(4):138-144.

35.

Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients.

van Bilsen WPH, van den Berg CHSB, Rijnders BJA, Brinkman K, Mulder JW, Gelinck LBS, Hoepelman AIM, Wit FWNM, van de Beek D, Prins JM.

AIDS. 2017 Jun 19;31(10):1415-1424. doi: 10.1097/QAD.0000000000001492.

PMID:
28375874
36.

Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia.

de Regt MJ, Murk JL, Schneider-Hohendorf T, Wattjes MP, Hoepelman AI, Arends JE.

JMM Case Rep. 2016 Aug 30;3(4):e005053. doi: 10.1099/jmmcr.0.005053. eCollection 2016 Aug.

37.

Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations.

Nuralitha S, Murdiyarso LS, Siregar JE, Syafruddin D, Roelands J, Verhoef J, Hoepelman AIM, Marzuki S.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e01867-16. doi: 10.1128/AAC.01867-16. Print 2017 May.

38.

Overcoming Outpatient Loss to Follow-up as a Barrier to Efficiently Instituting Hepatitis B Liver-related Care.

Lieveld FI, Arends JE, Amelung L, Dijk E, Gisolf EH, Vrolijk JM, van Erpecum KJ, Siersema PD, Spanier BW, Hoepelman AI, Richter C.

Clin Infect Dis. 2017 Jan 15;64(2):233-235. doi: 10.1093/cid/ciw746. Epub 2016 Nov 10. No abstract available.

PMID:
27989987
39.

Review of functional MRI in HIV: effects of aging and medication.

Hakkers CS, Arends JE, Barth RE, Du Plessis S, Hoepelman AI, Vink M.

J Neurovirol. 2017 Feb;23(1):20-32. doi: 10.1007/s13365-016-0483-y. Epub 2016 Oct 7. Review.

40.

 Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection.

Lieveld FI, Swaans N, Newsum AM, Ho CK, Schinkel J, Molenkamp R, van der Meer JT, Arends JE, Hoepelman AI, Wensing AM, Siersema PD, van Erpecum KJ, Boland GJ.

Ann Hepatol. 2016 Sep-Oct;15(5):696-704. doi: 10.5604/16652681.1212426.

41.

Maraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot Study.

Krikke M, Tesselaar K, Arends JE, Drylewicz J, Otto SA, van Lelyveld SF, Visseren FJ, Hoepelman AI.

Infect Dis Ther. 2016 Sep;5(3):389-404. doi: 10.1007/s40121-016-0115-0. Epub 2016 Jun 14.

42.

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice.

Arends JE, Kracht PA, Hoepelman AI; European Study Group for Viral Hepatitis (ESGVH).

Clin Microbiol Infect. 2016 Oct;22(10):846-852. doi: 10.1016/j.cmi.2016.05.027. Epub 2016 Jun 10. Review.

43.

Continuous intravenous infusion of enfuvirtide in a patient with a multidrug-resistant HIV strain.

Neijzen RW, Van Maarseveen EM, Hoepelman AI, Wensing AM, Bonora S, D'Avolio A, Mudrikova T.

Int J Clin Pharm. 2016 Aug;38(4):749-51. doi: 10.1007/s11096-016-0316-3. Epub 2016 May 14.

PMID:
27180258
44.

Clinical Management of Ebola Virus Disease in the United States and Europe.

Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J; Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe.

N Engl J Med. 2016 Feb 18;374(7):636-46. doi: 10.1056/NEJMoa1504874.

45.

Hospital Preparations for Viral Hemorrhagic Fever Patients and Experience Gained from Admission of an Ebola Patient.

Haverkort JJ, Minderhoud AL, Wind JD, Leenen LP, Hoepelman AI, Ellerbroek PM.

Emerg Infect Dis. 2016 Feb;22(2):184-91. doi: 10.3201/eid2202.151393.

46.

Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection.

Lieveld FI, Swaans N, Newsum AM, Ho CKY, Schinkel J, Molenkamp R, van der Meer JTM, Arends JE, Hoepelman AIM, Wensing AMJ, Siersema PD, Erpecum KJV, Boland GJ.

Ann Hepatol. 2016 Sep - Oct;15(5):696-704. doi: 10.5604/16652681.1212426.

47.

Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients.

van Lelyveld SF, Symons J, van Ham P, Connell BJ, Nijhuis M, Wensing AM, Hoepelman AI.

Int J Antimicrob Agents. 2016 Jan;47(1):84-90. doi: 10.1016/j.ijantimicag.2015.09.013. Epub 2015 Oct 25.

PMID:
26585497
48.

Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.

Nuralitha S, Siregar JE, Syafruddin D, Roelands J, Verhoef J, Hoepelman AI, Marzuki S.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):258-63. doi: 10.1128/AAC.00538-15. Print 2016 Jan.

49.

Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV/HCV coinfected patients.

Arends JE, van der Meer JT, Posthouwer D, Kortmann W, Brinkman K, van Assen S, Smit C, van der Valk M, van der Ende M, Schinkel J, Reiss P, Richter C, Hoepelman AI; Stichting HIV Monitoring/Nederlandse Vereniging van HIV Behandelaren Hepatitis Working Group; ATHENA national observational HIV cohort.

Neth J Med. 2015 Aug;73(7):324-30.

50.

Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.

Wensink GE, Schoffelen AF, Tempelman HA, Rookmaaker MB, Hoepelman AI, Barth RE.

PLoS One. 2015 Aug 26;10(8):e0136529. doi: 10.1371/journal.pone.0136529. eCollection 2015.

Supplemental Content

Loading ...
Support Center